Mezzion Pharma Co.,Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was KRW 16,139.81 million compared to KRW 3,280.66 million a year ago. Basic loss per share from continuing operations was KRW 604 compared to KRW 123 a year ago. Diluted loss per share from continuing operations was KRW 604 compared to KRW 123 a year ago. Basic loss per share was KRW 604 compared to KRW 123 a year ago.
For the six months, net loss was KRW 20,344.61 million compared to KRW 5,513.14 million a year ago. Basic loss per share from continuing operations was KRW 762 compared to KRW 207 a year ago. Diluted loss per share from continuing operations was KRW 762 compared to KRW 207 a year ago. Basic loss per share was KRW 762 compared to KRW 207 a year ago.